353 related articles for article (PubMed ID: 30429088)
1. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
[TBL] [Abstract][Full Text] [Related]
2. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract][Full Text] [Related]
3. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.
Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y
Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1.
Matsumoto E; Akiyama K; Saito T; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y; Suzuki T
Biochem J; 2020 Jun; 477(12):2237-2248. PubMed ID: 32453427
[TBL] [Abstract][Full Text] [Related]
5. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
[TBL] [Abstract][Full Text] [Related]
6. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
[TBL] [Abstract][Full Text] [Related]
8. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
9. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
10. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
[TBL] [Abstract][Full Text] [Related]
11. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma.
Liu H; Gong Z; Li K; Zhang Q; Xu Z; Xu Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):75. PubMed ID: 33602301
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
Das S; Anczuków O; Akerman M; Krainer AR
Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
14. SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.
Chen L; Luo C; Shen L; Liu Y; Wang Q; Zhang C; Guo R; Zhang Y; Xie Z; Wei N; Wu W; Han J; Feng Y
Cell Rep; 2017 Dec; 21(12):3406-3413. PubMed ID: 29262322
[TBL] [Abstract][Full Text] [Related]
15. Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer.
Yao G; Tang J; Yang X; Zhao Y; Zhou R; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S
Theranostics; 2020; 10(24):11144-11158. PubMed ID: 33042275
[No Abstract] [Full Text] [Related]
16. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
17. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
[TBL] [Abstract][Full Text] [Related]
19. Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14.
Feng JF; Yang WY; Wang YD; Xie G; Xu B; Dai CM; Zhang B; Li XH; Wang J; Yang YW
Oxid Med Cell Longev; 2022; 2022():8645830. PubMed ID: 36062189
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.
Katsuyama T; Li H; Comte D; Tsokos GC; Moulton VR
J Clin Invest; 2019 Dec; 129(12):5411-5423. PubMed ID: 31487268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]